FrancophonIA/ELRC3.0 huggingface dataset:
English: Valsartan Potassium-sparing diuretics, potassium supplements, salt substitutes containing potassium and other substances that may increase potassium levels
Icelandic: Kalíumsparandi þvagræsilyf, kalíumuppbót, saltauppbót sem inniheldur kalíum og annað sem getur hækkað kalíumþéttni
English: There are no clinical studies on fertility with Dafiro HCT.
Icelandic: Engar klínískar frjósemisrannsóknir hafa verið gerðar með Dafiro HCT.
English: • increased muscle tension
Icelandic: • aukin vöðvaspenna
English: How to store Dafiro HCT
Icelandic: Hvernig geyma á Dafiro HCT
English: Novartis Pharma S.A.S.
Icelandic: Novartis Pharma Services Inc.
English: If any of the above applies to you, do not take Dafiro HCT and talk to your doctor.
Icelandic: Ef eitthvað af framangreindu á við skal ekki nota Dafiro HCT og hafa samband við lækninn.
English: Due to the valsartan component, Dafiro HCT is contraindicated in patients with hepatic impairment (see sections 4.2 and 4.3).
Icelandic: Skert lifrarstarfsemi er frábending við notkun Dafiro HCT vegna þess að það inniheldur valsartan (sjá kafla 4.2 og 4.3).
English: Possible preventive measures such as limited exposure to sunlight and UV rays and, in case of exposure, adequate protection should be advised to the patients in order to minimise the risk of skin cancer.
Icelandic: Ráðleggja skal sjúklingum um hugsanlegar fyrirbyggjandi aðgerðir svo sem að takmarka útsetningu fyrir sólarljósi og UV geislum og nota nægilega vörn þegar þeir eru í sólarljósi til að minnka hættuna á húðkrabbameini.
English: Non-melanoma skin cancer: based on available data from epidemiological studies, cumulative dose-dependent association between hydrochlorothiazide and NMSC has been observed (see also sections 4.4 and 5.1).
Icelandic: Byggt á fyrirliggjandi upplýsingum úr faraldsfræðilegum rannsóknum hafa komið í ljós skammtaháð tengsl við uppsafnaðan skammt milli hýdróklórtíazíðs og húðkrabbameins sem ekki er sortuæxli (sjá einnig kafla 4.4 og 5.1).
English: Lethargy
Icelandic: Algengar
English: • mood changes
Icelandic: • breyting á bragðskyni
English: Dafiro HCT should be used only after correction of any pre-existing sodium and/or volume depletion.
Icelandic: Dafiro HCT skal aðeins nota eftir að natríumskortur og/eða minnkað blóðrúmmál hefur verið leiðrétt.
English: • medicines for the treatment of diabetes (oral agents such as metformin or insulins);
Icelandic: • lyfjum við sykursýki (lyf til inntöku svo sem metformin eða insúlín)
English: Biotransformation Hydrochlorothiazide is eliminated predominantly as unchanged compound.
Icelandic: Umbrot Hýdróklórtíazíð skilst aðallega út á óbreyttu formi.
English: Reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with ACE inhibitors, angiotensin II receptor antagonists including valsartan or thiazides.
Icelandic: Greint hefur verið frá afturkræfri aukningu á sermisþéttni litíums og eiturverkunum, við samhliða notkun litíums og ACE-hemla, angíótensín II viðtakablokka, þar með talið valsartan, eða tíazíða.
English: if you are taking any of the following medicines used to treat high blood pressure: an ACE inhibitor (for example enalapril, lisinopril, ramipril), in particular if you have diabetes-related kidney problems.
Icelandic: ACE-hemil (til dæmis enalapríl, lisinopríl, ramipríl) sérstaklega ef þú ert með nýrnakvilla sem tengjast sykursýki.
English: When pregnancy is diagnosed, treatment with AIIRAs should be stopped immediately, and if appropriate, alternative therapy should be started.
Icelandic: Verði kona þunguð skal stöðva meðferð með angíótensín II viðtakablokkum án tafar, og hefja aðra meðferð í staðinn, ef við á.
English: Thiazides potentiate the antihypertensive action of other antihypertensive drugs (e.g. guanethidine, methyldopa, beta-blockers, vasodilators, calcium channel blockers, ACE inhibitors, ARBs and Direct Renin Inhibitors [DRIs]).
Icelandic: Tíazíð auka blóðþrýstingslækkandi verkun annarra blóðþrýstingslækkandi lyfja (t.d. guanetidíns, metýldópa, betablokka, æðavíkkandi lyfja, kalsíumgangaloka, ACE-hemla, angíótensínblokka og renínhemla með beina verkun).
English: How to take Dafiro HCT
Icelandic: Hvernig nota á Dafiro HCT
English: Dafiro HCT combines three antihypertensive compounds with complementary mechanisms to control blood pressure in patients with essential hypertension: amlodipine belongs to the calcium antagonist class and valsartan to the angiotensin II antagonist class of medicines and hydrochlorothiazide belongs to the thiazide diuretics class of medicines.
Icelandic: Amlodipin tilheyrir flokki kalsíumgangaloka, valsartan tilheyrir flokki angíótensín II viðtakablokka og hýdróklórtíazíð tilheyrir þvagræsilyfjum af flokki tíazíða.
English: If you have accidentally taken too many Dafiro HCT tablets, talk to a doctor immediately.You may require medical attention.
Icelandic: Ef notaður er stærri skammtur en mælt er fyrir um Ef þú hefur tekið of margar Dafiro HCT töflur inn, skaltu tafarlaust leita til læknis.
English: Dafiro HCT 10 mg/320 mg/25 mg film-coated tablets
Icelandic: Dafiro HCT 10 mg/320 mg/25 mg filmuhúðaðar töflur
English: If Dafiro HCT is used during breast-feeding, doses should be kept as low as possible.
Icelandic: Ef konur sem hafa barn á brjósti nota Dafiro HCT skal nota eins litla skammta og hægt er.
English: Patients with primary hyperaldosteronism should not be treated with the angiotensin II antagonist valsartan as their renin-angiotensin system is not activated.
Icelandic: Ekki ætti að nota angíótensín II viðtakablokkann valsartan handa sjúklingum með frumkomið aldósterónheilkenni vegna þess að sjúkdómurinn hefur áhrif á renín-angíótensínkerfið.
English: If hypokalaemia develops during hydrochlorothiazide therapy, Dafiro HCT should be discontinued until stable correction of the potassium balance.
Icelandic: Ef blóðkalíumlækkun kemur fram meðan á meðferð með hýdróklórtíazíði stendur, skal stöðva meðferð með Dafiro HCT þar til kalíumþéttni hefur verið leiðrétt og hún helst stöðug.
English: • facial rash, joint pain, muscle disorder, fever (lupus erythematosus)
Icelandic: • útbrot í andliti, liðverkir, vöðvasjúkdómur, hiti (rauðir úlfar)
English: • decreased number of white blood cells
Icelandic: • fækkun hvítra blóðfrumna
English: Obstruction of the outflow tract of the left ventricle (e.g. hypertrophic obstructive cardiomyopathy and high grade aortic stenosis).
Icelandic: Heft flæði frá vinstri slegli (t.d. ofvaxtarhjartavöðvakvilli með teppu og mikil ósæðarþrengsli).
English: Due to the hydrochlorothiazide component, Dafiro HCT is contraindicated in symptomatic hyperuricaemia.
Icelandic: Vegna hýdróklórtíazíðhlutans, má ekki nota Dafiro HCT þegar þvagsýruhækkun í blóði með einkennum er til staðar.
English: • sleepiness
Icelandic: • svefnleysi
English: Dafiro HCT was studied in a double-blind, active controlled study in hypertensive patients.
Icelandic: HCT var rannsakað í tvíblindri samanburðarrannsókn með virkum samanburði hjá sjúklingum með háþrýsting.
English: Non cardiac chest pain
Icelandic: Brjóstastækkun hjá körlum
English: • anxiety
Icelandic: • kvíði
English: • blistering skin (sign of a condition called dermatitis bullous)
Icelandic: blöðrur á húð (einkenni kvilla sem kallast blöðruhúðbólga)
English: Dafiro HCT is contraindicated in patients with hypercalcaemia and should only be used after correction of any pre-existing hypercalcaemia.
Icelandic: Sjúklingar með blóðkalsíumhækkun mega ekki nota Dafiro HCT og einungis skal nota það eftir að blóðkalsíumhækkun sem er til staðar hefur verið leiðrétt.
English: If you stop taking Dafiro HCT
Icelandic: Ef hætt er að nota Dafiro HCT
English: Titanium dioxide (E171) Iron oxide, yellow (E172)
Icelandic: Títantvíoxíð (E171)
English: Based on available data from epidemiological studies, cumulative dose-dependent association between hydrochlorothiazide and NMSC has been observed.
Icelandic: Byggt á fyrirliggjandi upplýsingum úr faraldsfræðilegum rannsóknum hafa komið í ljós skammtaháð tengsl við uppsafnaðan skammt milli hýdróklórtíazíðs og húðkrabbameins sem ekki er sortuæxli.
English: • purple skin patches
Icelandic: • litabreytingar í húð
English: • cough
Icelandic: • roði
English: An increased risk of non-melanoma skin cancer (NMSC) [basal cell carcinoma (BCC) and squamous cell carcinoma (SCC)] with increasing cumulative dose of hydrochlorothiazide exposure has been observed in two epidemiological studies based on the Danish National Cancer Registry.
Icelandic: Í tveimur faraldsfræðilegum rannsóknum, sem byggja á skrá um krabbamein hjá Dönum, hefur komið í ljós aukin hætta á húðkrabbameini sem ekki er sortuæxli [grunnfrumukrabbamein (basal cell carcinoma) og flöguþekjukrabbamein (squamous cell carcinoma)] við útsetningu fyrir stækkandi uppsöfnuðum skammti af hýdróklórtíazíði.
English: Dafiro HCT 5 mg/160 mg/25 mg film-coated tablets are yellow, oval tablets with “NVR” on one side and “VEL” on the other side.
Icelandic: Dafiro HCT 5 mg/160 mg/25 mg filmuhúðaðar töflur eru gular, sporöskjulaga töflur, auðkenndar með „NVR“ á annarri hliðinni og „VEL“ á hinni hliðinni.
English: • frequent urination
Icelandic: • tíðari þvaglát
English: Uncommon Very rare
Icelandic: Sjaldgæfar Sjaldgæfar
English: Two large randomised, controlled trials (ONTARGET [ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial] and VA NEPHRON-D [The Veterans Affairs Nephropathy in Diabetes]) have examined the use of the combination of an ACE inhibitor with an ARB.
Icelandic: (ONTARGET [ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint
English: Amantadine
Icelandic: Niðurgangur
English: Pack sizes: 56, 98 or 280 film-coated tablets Multipacks of 280 tablets, comprising 4 cartons, each containing 70 tablets.
Icelandic: Fjölpakkningar með 280 töflum, sem samanstanda af 4 öskjum, sem hver inniheldur 70 töflur.
English: Dafiro HCT 10 mg/320 mg/25 mg film-coated tablets are brown-yellow, oval tablets with “NVR” on one side and “VFL” on the other side.
Icelandic: HCT 10 mg/320 mg/25 mg filmuhúðaðar töflur eru gulbrúnar, sporöskjulaga töflur, auðkenndar með „NVR“ á annarri hliðinni og „VFL“ á hinni hliðinni.
English: Dafiro HCT 10 mg/320 mg/25 mg film-coated tablets amlodipine/valsartan/hydrochlorothiaziade
Icelandic: HCT 10 mg/320 mg/25 mg filmuhúðaðar töflur amlodipin/valsartan/hýdróklórtíazíð
English: Weight increase
Icelandic: þyngdaraukning
English: Haemolytic anaemia
Icelandic: Frumueyðandi lyf
English: • medicines that may reduce the amount of potassium in your blood, such as diuretics (water tablets), corticosteroids, laxatives, amphotericin or penicillin G;
Icelandic: • lyfjum sem geta dregið úr magni natríums í blóði, svo sem þunglyndislyfjum, geðrofslyfjum og flogaveikilyfjum
English: Haemodynamically unstable heart failure after acute myocardial infarction.
Icelandic: Blóðaflfræðilega óstöðug hjartabilun eftir brátt drep í hjartavöðva.
English: Acute renal failure
Icelandic: Bráð þrönghornsgláka
English: Coordination abnormal
Icelandic: erfiðleikar við samhæfingu
English: Dafiro 10 mg/320 mg/25 mg film-coated tablets The active substances of Dafiro HCT are amlodipine (as amlodipine besylate), valsartan and hydrochlorothiazide.
Icelandic: HCT 10 mg/320 mg/25 mg filmuhúðaðar töflur Virku innihaldsefnin í Dafiro HCT eru amlodipin (sem amlodipinbesylate), valsartan og hýdróklórtíazíð.
English: Dafiro HCT 10 mg/160 mg/25 mg film-coated tablets
Icelandic: Dafiro HCT 10 mg/160 mg/25 mg filmuhúðaðar töflur
English: Dafiro HCT 10 mg/160 mg/12.5 mg film-coated tablets
Icelandic: Dafiro HCT 10 mg/160 mg/12,5 mg filmuhúðaðar töflur
English: Dafiro HCT 5 mg/160 mg/25 mg film-coated tablets
Icelandic: Dafiro HCT 5 mg/160 mg/25 mg filmuhúðaðar töflur
English: Dafiro HCT 5 mg/160 mg/12.5 mg film-coated tablets
Icelandic: Dafiro HCT 5 mg/160 mg/12,5 mg filmuhúðaðar töflur
English: Dafiro HCT 10 mg/160 mg/12.5 mg film-coated tablets are pale yellow, oval tablets with “NVR” on one side and “VDL” on the other side.
Icelandic: Dafiro HCT 5 mg/160 mg/12,5 mg filmuhúðaðar töflur eru hvítar, sporöskjulaga töflur, auðkenndar með „NVR“ á annarri hliðinni og „VCL“ á hinni hliðinni.
English: At week 8, the mean reductions in systolic/diastolic blood pressure were 39.7/24.7 mmHg with Dafiro HCT, 32.0/19.7 mmHg with valsartan/hydrochlorothiazide, 33.5/21.5 mmHg with amlodipine/valsartan, and 31.5/19.5 mmHg with amlodipine/hydrochlorothiazide.
Icelandic: Dafiro HCT, 32,0/19,7 mmHg hjá þeim sem fengu valsartan/hýdróklórtíazíð, 33,5/21,5 mmHg hjá þeim sem fengu amlodipin/valsartan og 31,5/19,5 mmHg hjá þeim sem fengu amlodipin/hýdróklórtíazíð.
English: Titanium dioxide (E171) Iron oxide, yellow (E172) Iron oxide, red (E172)
Icelandic: Rautt járnoxíð (E172)
English: The other ingredients are cellulose microcrystalline; crospovidone (type A); silica, colloidal anhydrous; magnesium stearate; hypromellose (substitution type 2910 (3 mPa.s)), macrogol 4000, talc, titanium dioxide (E171), yellow iron oxide (E172), red iron oxide (E172).
Icelandic: Önnur innihaldsefni eru örkristölluð sellulósa; crospovidon (gerð A); vatnsfrí kísilkvoða; magnesíumsterat; hýprómellósa (útskipt gerð 2910 (3 mPa s)); macrogol 4000; talkúm; títantvíoxíð (E171); gult járnoxíð (E172); rautt járnoxíð (E172).
English: Pyrexia
Icelandic: Dafiro
English: Dafiro HCT individual component
Icelandic: Dafiro HCT hvert um sig
English: • sleep disturbances
Icelandic: svefntruflanir
English: • anticonvulsant medicines and mood-stabilising medicines used to treat epilepsy and bipolar disorder (e.g. carbamazepine, phenobarbital, phenytoin, fosphenytoin, primidone);
Icelandic: (t.d. carbamazepin, fenobarbital, fenytoin, fosfenytoin, primidon)
English: This is a disease in which the adrenal glands make too much of the hormone aldosterone If this applies to you, the use of Dafiro HCT is not recommended.
Icelandic: Það er sjúkdómur sem felur í sér að nýrnahetturnar framleiða of mikið af hormóninu aldósteróni.
English: Dafiro HCT 5 mg/160 mg/25 mg film-coated tablets amlodipine/valsartan/hydrochlorothiaziade
Icelandic: HCT 5 mg/160 mg/25 mg filmuhúðaðar töflur amlodipin/valsartan/hýdróklórtíazíð
English: Visual impairment
Icelandic: Aukning lípíða
English: Gingival hyperplasia
Icelandic: Ofvöxtur tannholds
English: Dafiro HCT 5 mg/160 mg/25 mg film-coated tablets The active substances of Dafiro HCT are amlodipine (as amlodipine besylate), valsartan and hydrochlorothiazide.
Icelandic: Dafiro HCT 5 mg/160 mg/25 mg filmuhúðaðar töflur Virku innihaldsefnin í Dafiro HCT eru amlodipin (sem amlodipinbesylat), valsartan og hýdróklórtíazíð.
English: Mood swings
Icelandic: Sjaldgæfar Sundl
English: Dafiro HCT 5 mg/160 mg/12.5 mg film-coated tablets The active substances of Dafiro HCT are amlodipine (as amlodipine besylate), valsartan and hydrochlorothiazide.
Icelandic: Dafiro HCT 5 mg/160 mg/12,5 mg filmuhúðaðar töflur Virku innihaldsefnin í Dafiro HCT eru amlodipin (sem amlodipinbesylat), valsartan og hýdróklórtíazíð.
English: Dafiro HCT 10 mg/160 mg/25 mg film-coated tablets amlodipine/valsartan/hydrochlorothiaziade
Icelandic: HCT 10 mg/160 mg/25 mg filmuhúðaðar töflur amlodipin/valsartan/hýdróklórtíazíð
English: Hepatitis
Icelandic: höfuðverkur
English: Dafiro HCT 10 mg/160 mg/25 mg
Icelandic: HCT 10 mg/160 mg/25 mg
English: Dafiro HCT 5 mg/160 mg/25 mg
Icelandic: HCT 5 mg/160 mg/25 mg
English: Dafiro HCT 10 mg/160 mg/25 mg film-coated tablets are brown-yellow, oval tablets with “NVR” on one side and “VHL” on the other side.
Icelandic: HCT 10 mg/160 mg/25 mg filmuhúðaðar töflur eru gulbrúnar, sporöskjulaga töflur, auðkenndar með „NVR“ á annarri hliðinni og „VHL“ á hinni hliðinni.
English: Confusion
Icelandic: slappleiki
English: Dafiro HCT 5 mg/160 mg/12.5 mg film-coated tablets amlodipine/valsartan/hydrochlorothiaziade
Icelandic: HCT 5 mg/160 mg/12,5 mg filmuhúðaðar töflur amlodipin/valsartan/hýdróklórtíazíð
English: Dafiro HCT 10 mg/160 mg/12.5 mg film-coated tablets amlodipine/valsartan/hydrochlorothiaziade
Icelandic: HCT 10 mg/160 mg/12,5 mg filmuhúðaðar töflur amlodipin/valsartan/hýdróklórtíazíð
English: Muscular weakness
Icelandic: Vöðvakippir
English: Dafiro HCT 10 mg/160 mg/25 mg film-coated tablets The active substances of Dafiro HCT are amlodipine (as amlodipine besylate), valsartan and hydrochlorothiazide.
Icelandic: HCT 10 mg/160 mg/25 mg filmuhúðaðar töflur Virku innihaldsefnin í Dafiro HCT eru amlodipin (sem amlodipinbesylate), valsartan og hýdróklórtíazíð.
English: The other ingredients are cellulose microcrystalline; crospovidone (type A); silica, colloidal anhydrous, magnesium stearate, hypromellose (substitution type 2910 (3 mPa.s)), macrogol 4000, talc, yellow iron oxide (E172).
Icelandic: Önnur innihaldsefni eru örkristölluð sellulósa; crospovidon (gerð A); vatnsfrí kísilkvoða; magnesíumsterat; hýprómellósa (útskipt gerð 2910 (3 mPa s)); macrogol 4000; talkúm; gult járnoxíð (E172).
English: • ankle swelling (oedema)
Icelandic: • þaninn kviður (magabólga)
English: Dafiro HCT 10 mg/160 mg/12.5 mg film-coated tablets The active substances of Dafiro HCT are amlodipine (as amlodipine besylate), valsartan and hydrochlorothiazide.
Icelandic: HCT 10 mg/160 mg/12,5 mg filmuhúðaðar töflur Virku innihaldsefnin í Dafiro HCT eru amlodipin (sem amlodipinbesylat), valsartan og hýdróklórtíazíð.
English: • sudden wheeziness, chest pain, shortness of breath or difficulty breathing
Icelandic: skyndileg þrengsli í öndunarvegi, brjóstverkur, mæði eða öndunarerfiðleikar
English: The other ingredients are cellulose microcrystalline; crospovidone (type A); silica, colloidal anhydrous; magnesium stearate; hypromellose (substitution type 2910 (3 mPa.s)), macrogol 4000, talc, titanium dioxide (E171).
Icelandic: Önnur innihaldsefni eru örkristölluð sellulósa; crospovidon (gerð A); vatnsfrí kísilkvoða; magnesíumsterat; hýprómellósa (útskipt gerð 2910 (3 mPa s)); macrogol 4000; talkúm; títantvíoxíð (E171).
English: The other ingredients are cellulose microcrystalline; crospovidone (type A); silica, colloidal anhydrous, magnesium stearate, hypromellose (substitution type 2910 (3 mPa.s)), macrogol 4000, talc, titanium dioxide (E171), yellow iron oxide (E172).
Icelandic: Önnur innihaldsefni eru örkristölluð sellulósa; crospovidon (gerð A); vatnsfrí kísilkvoða; magnesíumsterat; hýprómellósa (útskipt gerð 2910 (3 mPa s)); macrogol 4000; talkúm; títantvíoxíð (E171); gult járnoxíð (E172).
English: Non-melanoma skin cancer (Basal cell carcinoma and Squamous cell carcinoma)
Icelandic: Húðkrabbamein sem ekki er sortuæxli (grunnfrumukrabbamein og flöguþekjukrabbamein)
English: • inflammation of the liver (hepatitis)
Icelandic: • litíum (lyf við sumum gerðum þunglyndis)
English: Each film-coated tablet contains 10 mg amlodipine (as amlodipine besylate), 160 mg valsartan and 25 mg hydrochlorothiazide.
Icelandic: Hver filmuhúðuð tafla inniheldur amlodipin 10 mg (sem amlodipinbesylat), valsartan 160 mg og hýdróklórtíazíð 25 mg.
English: Each film-coated tablet contains 5 mg amlodipine (as amlodipine besylate), 160 mg valsartan and 25 mg hydrochlorothiazide.
Icelandic: Hver filmuhúðuð tafla inniheldur amlodipin 5 mg (sem amlodipinbesylat), valsartan 160 mg og hýdróklórtíazíð 25 mg.
English: Intrahepatic cholestasis, jaundice
Icelandic: Úttaugakvilli, taugakvilli
English: Common Common
Icelandic: Almenn atriði
English: Uncommon Common Uncommon Rare
Icelandic: Svefnleysi/svefntruflanir Sjaldgæfar Sjaldgæfar
English: Agranulocytosis, bone marrow failure
Icelandic: Gangstol, gangtruflanir Sjaldgæfar Þróttleysi
English: Marked hypercalcaemia may be evidence of hidden hyperparathyroidism.
Icelandic: Ljósnæmisáhrif hýdróklórtíazíðs geta hugsanlega verið þáttur sem leiðir til húðkrabbameins sem ekki er sortuæxli.
English: Each film-coated tablet contains 5 mg amlodipine (as amlodipine besylate), 160 mg valsartan and 12.5 mg hydrochlorothiazide.
Icelandic: Hver filmuhúðuð tafla inniheldur amlodipin 5 mg (sem amlodipinbesylat), valsartan 160 mg og hýdróklórtíazíð 12,5 mg.
English: There is evidence that the concomitant use of ACE inhibitors, ARBs or aliskiren increases the risk of hypotension, hyperkalaemia, and decreased renal function (including acute renal failure).
Icelandic: Vísbendingar eru um að samhliðanotkun ACE-hemla, angíótensín II viðtakablokka eða aliskirens auki hættu á blóðþrýstingslækkun, blóðkalíumhækkun og skerðingu á nýrnastarfsemi (þ.m.t. bráðri nýrnabilun).
English: Amlodipine, valsartan and hydrochlorothiazide exhibit linear pharmacokinetics.
Icelandic: Lyfjahvörf amlodipins, valsartans og hýdróklórtíazíðs eru línuleg.
English: • dizziness, fainting on standing up
Icelandic: sundl, yfirlið þegar staðið er upp
English: Erythema multiforme
Icelandic: • meltingarerfiðleikar
English: Amlodipine Valsartan HCT
Icelandic: Amlodipin/valsartan/hýdróklórtíazíð
English: Grapefruit and grapefruit juice should not be consumed by people who are prescribed Dafiro HCT.
Icelandic: Þeir sem hafa fengið ávísað Dafiro HCT eiga ekki að neyta greipaldins eða greipaldinsafa.
English: Posology
Icelandic: Sjónskerðing
English: Pack size l t o r
Icelandic: Innri umbúðir Pakkningastær ð i
English: (Invented)name Strength Pharmaceutical Form
Icelandic: ESB markaðsleyfisnúmer
English: Annex III
Icelandic: Viðauki III
English: After the Commission decision the Member State competent authorities, in liaison with the reference Member State, will update the product information as required.
Icelandic: Eftir CD munu yfirvöld aðildarlanda, í samvinnu við viðmiðunarland, uppfæra upplýsingar um lyfið eftir þörfum.
English: The valid summary of product characteristics, labelling and package leaflet are the final versions achieved during the Coordination group procedure.
Icelandic: Gild samantekt á eiginleikum lyfs, áletranir og fylgiseðill eru lokaútgáfur sem fengust meðan á ferli samræmingarhópsins (Coordination group) stóð.
English: Note: This SmPC, labelling and packages leaflet is the version valid at the time of Commission decision.
Icelandic: Þessi samantekt á eiginleikum lyfs, áletranir og fylgiseðill er sú útgáfa sem er í gildi við CD (Commission Decision)
English: Summary of product characteristics, labelling and package leaflet
Icelandic: Samantekt á eiginleikum lyfs, áletranir og fylgiseðill
English: Therefore, this SmPC, labelling and package leaflet may not necessarily represent the current text.
Icelandic: Það er því ekki víst að þessi samantekt á eiginleikum lyfs, áletranir og fylgiseðill séu í samræmi við gildandi texta.
English: EU/1/15/1032/001 Zerbaxa
Icelandic: EU/1/15/1032/001
English: 1 g / 0.5 g Powder for concentrate for solution for infusion
Icelandic: 1 g / 0.5 g Stofn fyrir innrennslisþykkni, lausn
English: Pack size
Icelandic: Zerbaxa
English: Strength Pharmaceutical form
Icelandic: Lyfjaform Íkomuleið Innri umbúðir
English: You will not give yourself this medicine.
Icelandic: Þú munt ekki gefa sjálfum þér lyfið.
English: The majority (>90%) of healthcare professionals found Dzuveo easy to use.
Icelandic: Meirihluti (>90%) heilbrigðisstarfsmanna fannst auðvelt að nota Dzuveo.
English: If you are having a blood test ensure your doctor knows you are taking this medicine.
Icelandic: Ef þú ert á leið í blóðprufu skaltu láta lækninn vita að þú sért að taka þetta lyf.
English: 35, 80339 Munich, Germany.
Icelandic: 35, 80339 Munchen, Þýskaland.
English: After receiving a dose you will not be given another dose for at least one hour.
Icelandic: Eftir að þú færð skammt verður þér ekki gefinn annar skammtur í að minnsta kosti eina klukkustund.
English: Do not drink alcohol while using Dzuveo.
Icelandic: Ekki drekka áfengi meðan þú notar Dzuveo.
English: Each pack contains either 5 or 10 pouches.
Icelandic: Hver pakkning inniheldur annað hvort 5 eða 10 poka.
English: Phone: +49 - 89-893 119 22
Icelandic: Sími: +49 - 89-893 119 22 Fax:
English: By reporting side effects, you can help provide more information on the safety of this medicine.
Icelandic: Með því að tilkynna aukaverkanir er hægt að hjálpa til við að auka upplýsingar um öryggi lyfsins.
English: The frequencies are defined as:
Icelandic: Tíðni þeirra er skilgreind sem:
English: - If you have a serious lung or breathing problem
Icelandic: - Ef þú ert með alvarleg lungna- eða öndunarvandamál